If GHK-Cu is not bioavailable orally, its benefits might be limited to topical or injectable forms
doi:10.5811/westjem.2018.8.38829
Aging 12 , 1674416758 (2020)
BPC-157 is a research-stage compound without the extensive Phase I, II, and III clinical trials that FDA-approved medications undergo
Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides
Interrupting or postponing treatment with vitamin B12 causes harm, both physically and psychologically